
Valmicare Pharmaceuticals Private Limited
About Valmicare Pharmaceuticals Private Limited
Data last updated:
Valmicare Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 January 2014.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U01224TG2014PTC092519. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Gajula Padma and Gajula Shekhar Chandra.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at H.No.4 – 38 – 106 Deena Bandhu Colony Venkateswara Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2019, the company reported a revenue of ₹12.91 Lakh, a decline of 54% compared to the previous year. For the same year it recorded a net profit of ₹31,219 (net margin 2.4%) and EBITDA of ₹43,967 (EBITDA margin 3.4%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years.
Company details
CIN history
Valmicare Pharmaceuticals has one previous CIN (Corporate Identification Number): U01224AP2014PTC092519. The current CIN is U01224TG2014PTC092519, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01224TG2014PTC092519 | Current |
| U01224AP2014PTC092519 | Previous |
Contact details
Valmicare Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No.4 – 38 – 106 Deena Bandhu Colony Venkateswara Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Valmicare Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Valmicare Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Valmicare Pharmaceuticals Private Limited, buy the company report.
Financials of Valmicare Pharmaceuticals Private Limited
FY 2019 filings availableValmicare Pharmaceuticals Private Limited reported revenue of ₹12.91 Lakh (down 54% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over three years, including a 54% fall in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43,967 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31,219 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Valmicare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Valmicare Pharmaceuticals Private Limited
Valmicare Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gajula Padma | Director | 28 Nov 2016 | 9 Years 11 Months | As last reported |
| Gajula Shekhar Chandra | Director | 27 Jan 2014 | 12 Years 9 Months | As last reported |
Peer comparison
Valmicare Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Enrico Scientific Private Limited | ₹13.02 Lakh (FY 2024) | -62.0% | Gurugram, Haryana, India | |||
| RMC Performance Chemicals Private Limited | ₹12.96 Lakh (FY 2024) | -21.0% | Jalgaon, Maharashtra, India | |||
| Aavn Pharmaceuticals (OPC) Private Limited | ₹12.92 Lakh (FY 2025) | -18.0% | Secunderabad, Telangana, India | |||
| Valmicare Pharmaceuticals Private Limitedthis company | ₹12.91 Lakh (FY 2019) | ₹31,219 | 2.4% | -54.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Valmicare Pharmaceuticals Private Limited, buy the company report.
Auditor
Valmicare Pharmaceuticals Private Limited is audited by PADARTHI & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PADARTHI & ASSOCIATES | FY 2018 | 010574S |
Shareholding
The shareholding of Valmicare Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Valmicare Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Valmicare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Valmicare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Valmicare Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Valmicare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Valmicare Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Ramireddy Govardhan Reddy ceased to be Director on 02 Dec 2016.
Frequently asked questions
Valmicare Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Valmicare Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 27 January 2014 and is registered under CIN U01224TG2014PTC092519. The company has been struck off by the Registrar of Companies and is no longer operational.
Valmicare Pharmaceuticals had 2 directors:
- Gajula Padma - Director
- Gajula Shekhar Chandra - Director
The CIN (Corporate Identification Number) of Valmicare Pharmaceuticals is U01224TG2014PTC092519. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Valmicare Pharmaceuticals is at H.No.4 – 38 – 106 Deena Bandhu Colony Venkateswara Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Valmicare Pharmaceuticals was incorporated on 27 January 2014. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Valmicare Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Valmicare Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Valmicare Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
The peers of Valmicare Pharmaceuticals by revenue are Enrico Scientific Private Limited, RMC Performance Chemicals Private Limited, Aavn Pharmaceuticals (OPC) Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramireddy Govardhan Reddy ceased to be Director on 02 Dec 2016. Gajula Padma was appointed as Director on 28 Nov 2016. Gajula Shekhar Chandra was appointed as Director on 27 Jan 2014.

